ICO News

CyberVein (CVT) Crypto Total Market Capitalization Makes It to $33963839 as Price Reaches $0.032191


CyberVein (CVT) traded up 2.69 percent to dollar in the last 24h time period ending 02:00 on August 25th EST. CyberVein at this time has a total market cap of $33,963,839 and its 24 hour volume is around $132,170. Within the interval covering the past seven days, CyberVein is -14.38 percent against the dollar along with a move of 1.00 percent inside the past hr.

Now look at how other similar currencies have faired in the last 24 hours:

  • Nexus (NXS) is now trading at $0.81 against the USD, a 5.64 percent change since this time yesterday. The Bitcoin price for NXS currently, is 0.00012069 BTC.
  • Emercoin (EMC) is now trading at $1.73 against the USD, a -13.47 percent change since this time yesterday. The Bitcoin price for EMC currently, is 0.00025583 BTC.
  • Tierion (TNT) is now trading at $0.02 against the USD, a 6.38 percent change since this time yesterday. The Bitcoin price for TNT currently, is 0.00000280 BTC.

CyberVein Data

CyberVein has a max supply of exactly 1,055,084,622 coins. It launched on 4th March, 2018.

CryptoCompare claims that: “The CyberVein platform is a Distributed Ledger System that allows for the decentralized management of complex datasets on the blockchain, without requiring centralized storage providers. CyberVein (CVT) is an ERC20 compliant token in the Ethereum network.”

Several helpful url links are below, in case you want to get more information concerning CyberVein:

CVT: Trading Info

You can get CVT at trading exchanges such as HitBTC, BitZ, IDEX,

It’s not necessarily always possible to buy cryptocurrency like CyberVein right away using USD. Market players trying to obtain CVT may perhaps need to first of all pick up Bitcoin or ETH from an exchange which offers dollar trading pairs for instance Coinbase or perhaps GDAX. Buyers may then make use of this Bitcoin or Ethereum to buy CyberVein using one of the exchanges outlined above.



READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.